Infinity Laboratories expands testing capabilities with developed method for Hydroxychloroquine (HCQ)
CASTLE ROCK, CO – April 16, 2020 – Today Infinity Laboratories (infinitylaboratories.com) added a validated method for Hydroxychloroquine to its expanding catalog of capabilities and is now receiving final product samples for potency testing.
Hydroxychloroquine (HCQ) is an antimalarial drug effective in the treatment of various autoimmune rheumatic diseases including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) that is under investigation in clinical trials for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection, and treatment of patients with mild, moderate, and severe COVID-19.
(https://ncbi.nlm.nih.gov/pmc/articles/PMC5137978/ and https://www.cdc.gov/coronavirus/2019-ncov/hcp/therapeutic-options.html)
Method development is the process of proving that an analytical method is acceptable for use to measure the concentration of an API in a specific compounded dosage form which allow simplified procedures to be employed to verify that an analysis procedure, accurately and consistently will deliver a reliable measurement of an active ingredient in a compounded preparation. The analytical method validation is essential for method development and extensive testing is performed to display specificity, linearity, accuracy, precision, range, detection limit, quantization limit, and robustness. In summary, analytical method development and validation allows us to confirm that an accurate and reliable potency measurement of a pharmaceutical preparation can be performed.
For more information contact:
SVP, Commercial Operations
Infinity Laboratories Announces Hiring of New Senior Vice President of Commercial Operations
CASTLE ROCK, CO – March 22, 2023 - Infinity Laboratories is proud to announce the hiring of Hank Nowak as our new Senior Vice President of Commercial Operations. Mr. Nowak will be responsible for leading the sales and marketing strategy of the company, driving organic...
Infinity Laboratories announces the acquisition of EKG Life Sciences Solutions, LLC
CASTLE ROCK, CO – May 9, 2022 – Infinity Laboratories (infinitylaboratories.com) is proud to announce the acquisition of EKG Life Sciences Solutions, LLC (EKG Labs) in St. Louis, MO. Founded in 2013, EKG Labs is a privately-held, GMP compliant, and FDA regulated...
BIOMEDevices Smart Event
UNCOVER the latest innovation #BIOMEDevicesSmartEvent We’re thrilled to announce that we’ll be participating at BIOMEDevice Silicon Valley! Come see us at Booth#320 BIOMEDevice Silicon Valley, formerly known as BIOMEDevice San Jose, returns this winter. As Silicon...
Contact us today
Relevant, value-driven products and services
Experience how Infinity Laboratories
goes Beyond Testing to meet your needs